Affiliation:
1. Department of Reproductive Medicine, Dexeus University Hospital, 08028 Barcelona, Spain
2. Faculty of Medicine and Health Sciences, University of Ghent, 9000 Gent, Belgium
Abstract
Background. Triggering final oocyte maturation is a key step of ovarian stimulation. Although previous studies demonstrated a negative association between female BMI and serum hCG levels, little evidence is available regarding the association between oocyte yield and patients’ BMI. The scope of the current study was to examine whether the efficiency of the r-hCG and triptorelin to trigger final oocyte maturation may be associated with patients’ BMI or weight. Methods. This is a retrospective observational study including 5190 ovarian stimulation cycles performed between January 2019 and September 2022 in the Reproductive Medicine Department of Dexeus University Hospital. Cycles were analyzed according to the type of trigger (triptorelin vs. r-hCG vs. dual). The primary outcome measures were oocyte maturation rate (MII/oocytes) and FOI (oocytes/AFC); secondary outcomes were oocyte and MII yield. Results. Multivariable regression analysis, adjusting for confounding factors, demonstrated that BMI was not associated with oocyte maturation rate (OR: 1.00 [95%CI: 0.99; 1.01]), FOI (Beta 0.52 [95%CI: −0.49; 1.54]), number of oocytes (Beta 0.02 [95%CI: −0.08; 0.13]) or MIIs (Beta 0.01 [95%CI: −0.08; 0.10]) retrieved. Similarly, all analyses conducted considering patients’ weight failed to reveal any association. Conclusion. Our study demonstrates that, independent of the type of trigger, patients’ BMI and weight are not associated with oocyte yield, maturation, or FOI.
Reference24 articles.
1. Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment;Abbara;Endocr. Rev.,2018
2. Pharmaceutical Options for Triggering of Final Oocyte Maturation in ART;Castillo;BioMed Res. Int.,2014
3. Klement, A.H., and Shulman, A. (2017). hCG Triggering in ART: An Evolutionary Concept. Int. J. Mol. Sci., 18.
4. Effect of a “Dual Trigger” Using a GnRH Agonist and hCG on the Cumulative Live-Birth Rate for Normal Responders in GnRH-Antagonist Cycles;Gao;Front. Med.,2021
5. Lunenfeld, B., and Insler, V. (1999). From Animal Gonadotrophins to Recombinant FSH, Ladybrook Publishing.